Cognitive Outcomes after DEXmedetomidine sedation in cardiac surgery: CODEX randomised controlled trial protocol
Introduction Older patients undergoing cardiac surgery carry the highest risk for developing major postoperative neurocognitive disorder (postoperative NCD or P-NCD) with up to 25% incidence 3 months after surgery. P-NCD is associated with significant morbidity, mortality, loss of independence, prem...
Main Authors: | Angela Jerath, Frédérick D'Aragon, Philip Jones, George Djaiani, Summer Syed, Lilia Kaustov, Peter Hedlin, Raja Rajamohan, Etienne J. Couture, Amara Singh, Josiane CS Mapplebeck, Sophia Wong, Beverley Anne Orser |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/4/e046851.full |
Similar Items
-
Sedation and the potential application of dexmedetomidine: Sedation and dexmedetomidine
by: Lađević Nebojša, et al.
Published: (2016-01-01) -
Dexmedetomidine sedation in ICU
by: Soo-Bong Yu
Published: (2012-05-01) -
Dexmedetomidine for sedation of cardiosurgical patients
by: И. А. Козлов, et al.
Published: (2015-10-01) -
Dexmedetomidine for Sedation during Withdrawal of Support
by: Chris O’Hara, et al.
Published: (2015-08-01) -
The use of dexmedetomidine in intensive care sedation
by: Massimo Antonelli, et al.
Published: (2013-05-01)